Taylor & Francis Group

SHERPA: Unknown

People

  1. Castro-Malaspina
    Castro-Malaspina
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Jakubowski
    Jakubowski
  5. Papadopoulos
    Papadopoulos
  6. Young
    Young
  7. Chou
    Chou
  8. Devlin
    Devlin
  9. Brown
    Brown
  10. DeRespiris
    DeRespiris

Groups

  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)
  7. Survivorship Research (4)
  8. CTCR Scholars (2)
  9. DigITs Research Group (2)
  10. Executive Committee, Center for Hematologic Malignancies (2)
Search Within
  1. "Hugo Castro-Malaspina"
Formats
  1. Journal Article (5)
Groups
  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Hugo Castro-Malaspina (5)
  2. Miguel-Angel Perales (5)
  3. Sergio Giralt (5)
  4. Ann Jakubowski (4)
  5. Esperanza Papadopoulos (4)
  6. Craig Sauter (3)

More People

Years
  1. 2022 (1)
  2. 2017 (1)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (1)
Publications
  1. Leukemia and Lymphoma (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation
    Journal Article

    Lin, A.; Brown, S.; Maloy, M.; Ruiz, J. D.; Devlin, S.; DeRespiris, L.; Proli, A.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant
    Journal Article

    Goldberg, J. D.; Zheng, J.; Ratan, R.; Small, T. N.; Lai, K. C.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
    Journal Article

    Ceberio, I.; Devlin, S. M.; Sauter, C.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S.; Ponce, D. M.; Lechner, L.; Maloy, M. A.; Goldberg, J. D.; more...
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
    Journal Article

    Sauter, C. S.; Chou, J. F.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Young, J. W.; Scordo, M.; Giralt, S.; Castro-Malaspina, H.
    Leukemia and Lymphoma (2014)

    Fulltext@MSK | Save
  • Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant
    Journal Article

    Goldberg, J. D.; Chou, J. F.; Horwitz, S.; Teruya-Feldstein, J.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H.; Giralt, S.; Jakubowski, A. A.; Koehne, G.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save